International Patent: POLYNUCLEOTIDE FOR ENHANCING POLYPEPTIDE EXPRESSION, AND NUCLEIC ACID CONSTRUCT AND USE THEREOF

GENEVA, July 6 -- MAXIRNA (SHANGHAI) PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/146142) for “POLYNUCLEOTIDE FOR ENHANCING POLYPEPTIDE EXPRESSION, AND NUCLEIC ACID CONSTRUCT AND USE THEREOF”. With publication no. WO/2026/139059, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....